WaferGen, Inc. sells an analyzer and reagent kits for single cell research, based on real-time PCR. The system is useful for the analysis of trace amount of DNA in specimens from pharmaceutical companies or for clinical testing labs. The acquisition will be done by the US subsidiary Takara Bio USA Holdings.
Takara Bio news release, May 13, 2016
Takara Bio to acquire US WaferGen Bio-systems Inc. for up to 50 mill USD